Pharmacogenomics

Can pharmacogenetics help smokers quit?
pp. 1137-1140(4)
Authors: Munafò, Marcus; Lerman, Caryn

Could gene therapy prevent the effects of irradiation exposure?
pp. 1141-1145(5)
Author: Greenberger, JS

Using new `chips' in the next level of gene hunting
pp. 1147-1151(5)

Microarrays Technologies 2006: an overview
pp. 1153-1158(6)
Author: Hardiman, Gary

DOPA decarboxylase gene is associated with nicotine dependence
pp. 1159-1166(8)
Authors: Zhang, Heping; Ye, Yuanqing; Wang, Xueqing; Gelernter, Joel; Ma, Jennie Z; Li, Ming D

Gene-expression signatures in oncology diagnostics
pp. 1167-1173(7)
Authors: Mazumder, Abhijit; Wang, Yixin

Overview of the pharmacoeconomics of pharmacogenetics
pp. 1175-1184(10)
Authors: Dervieux, Thierry; Bala, Mohan V

Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology
pp. 1185-1198(14)
Authors: Mitra, Amit K; Agrawal, Devendra K

Could endogenous substrates of drug-metabolizing enzymes influence constitutive physiology and drug target responsiveness?
pp. 1199-1210(12)
Authors: Ozdemir, Vural; Gunes, Arzu; Dahl, Marja-Liisa; Scordo, M Gabriella; Williams-Jones, Bryn; Someya, Toshiyuki

Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping
pp. 1211-1221(11)
Authors: Innocenti, Federico; Ratain, Mark J

Search for shortcuts on the critical path to market: US FDA perspectives from the diagnostic side
pp. 1223-1227(5)
Authors: Gutman, Steven; Hackett, Joseph